Ciprofibrate
((logo of the responsible entity))
Lipanor belongs to a group of medicines called fibrates. These medicines are used to reduce the level of fats (lipids) in the blood. Examples of such fats include triglycerides. Lipanor is used in combination with a low-fat diet and other non-pharmacological treatments, such as physical exercise and weight loss, which aim to reduce the level of fats in the blood.
Do not take the medicine if any of the above conditions apply to the patient. In case of doubts, consult a doctor or pharmacist before taking Lipanor.
Before starting to take Lipanor, discuss it with your doctor or pharmacist if:
In case of doubts whether any of the above conditions apply to the patient, consult a doctor or pharmacist before starting to take Lipanor.
Taking Lipanor may affect the results of some blood tests. During treatment, the doctor may order blood tests to assess liver function. If the patient is to have other blood tests, they should inform the person performing the test that they are taking Lipanor.
Tell your doctor or pharmacist about all medicines the patient is currently taking or has recently taken, as well as any medicines they plan to take. This is because Lipanor may interact with other medicines. Also, some medicines may interact with Lipanor. Inform your doctor if the patient is taking any of the following medicines:
One of the side effects of taking Lipanor is muscle disorders. Consuming large amounts of alcohol may increase the risk of such disorders. Therefore, limit alcohol consumption while taking Lipanor. Consult a doctor for detailed advice.
Do not take Lipanor if:
If the patient is pregnant, breastfeeding, or suspects she may be pregnant, or plans to have a child, she should consult a doctor or pharmacist before taking this medicine.
While taking Lipanor, the patient may experience dizziness, drowsiness, and fatigue. If such symptoms occur, do not drive vehicles, use tools, or operate machinery.
If the patient has been diagnosed with intolerance to some sugars, they should consult a doctor before taking the medicine.
The medicine contains less than 1 mmol (23 mg) of sodium per capsule, which means the medicine is considered "sodium-free".
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Take the medicine orally. It is important to follow a suitable diet while taking Lipanor. If you feel that the effect of the medicine is too strong or too weak, consult your doctor. Do not change the dose of the medicine yourself.
The recommended dose is 1 capsule once a day. Do not take more than 1 capsule a day.
If you take more than the recommended dose of Lipanor, contact your doctor or go to the nearest hospital immediately. Take the packaging of the medicine with you so that the doctor knows what medicine has been taken.
If you forget to take a dose, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose. Do not take a double dose to make up for the missed dose.
Take Lipanor for as long as your doctor tells you to. Do not stop taking Lipanor just because you feel better. If you stop taking the medicine, your condition may worsen. If you have any further doubts about taking this medicine, consult your doctor or pharmacist.
Like all medicines, Lipanor can cause side effects, although not everybody gets them.
Common(may affect up to 1 in 10 people):
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C, PL-02 222 Warsaw, Tel.: +48 22 49 21 301, Fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. By reporting side effects, you can help provide more information on the safety of this medicine.
Do not store above 25°C. Keep the medicine out of the sight and reach of children. Do not use this medicine after the expiry date stated on the carton and blister. The expiry date refers to the last day of the month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Greenish-olive colored cap and ivory colored body gelatin capsules, containing a fine white to off-white powder. Pack size: 30 capsules (3 blisters of 10 capsules).
Sanofi Winthrop Industrie, 82, Avenue Raspail, 94250 Gentilly, France
Sanofi-Winthrop Industrie, 1, rue de la Vierge, Ambarès et Lagrave, 33565 Carbon Blanc Cedex, France, Opella Healthcare Poland Sp. z o.o., Branch in Rzeszów, ul. Lubelska 52, 35-233 Rzeszów. For more information, contact the local representative of the responsible entity: Sanofi Sp. z o.o., ul. Marcina Kasprzaka 6, 01-211 Warsaw, Tel.: +48 22 280 00 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.